Stocks
15 articlesLook for pieces that explain risk tolerance, asset classes and compound returns, compare adjacent choices and show how brokerage accounts, fund expense ratios and stock ownership appears in applications, disclosures, statements or official pages.
Warren Buffett's $187 Billion Cash Move Raises Market Alarm
As U.S. stocks hit record highs, Warren Buffett's Berkshire Hathaway has quietly sold more equities than it bought for 13 straight quarters, amassing nearly $400 billion in cash and signaling deep concern about market valuations
Delta’s Premium Strategy Shields Profits Despite Record Fuel Costs
Delta Air Lines posted strong revenue growth and raised its dividend even as it faced its largest-ever quarterly fuel bill, highlighting how its focus on premium cabins and loyalty programs is changing the airline’s financial playbook
Goldman Sachs Doubles Down on SanDisk With $2,200 Price Target
SanDisk stock has soared over 700% in 2026, and Goldman Sachs now projects even more upside. The firm’s new $2,200 target highlights a sharp divergence from Wall Street consensus and signals a major shift in semiconductor earnings expectations
Ionis Pharmaceuticals Stock Plunges After Consecutive Drug Setbacks
Ionis Pharmaceuticals shares tumbled nearly 29% in two days after a failed heart drug trial and a partner’s exit from Huntington’s disease programs, raising questions about future growth and competition in the biotech sector
Bank of America Sees Coca-Cola Stock Undervalued Before Earnings
Coca-Cola’s 63-year dividend growth streak and steady margins have Bank of America raising its price target, but investors face risks from global demand shifts and currency swings
Tesla-SpaceX Merger Hopes Face Cash Burn and Regulatory Hurdles
Tesla’s potential merger with SpaceX is fueling investor speculation, but analysts warn that heavy spending and regulatory barriers could limit any near-term upside for shareholders betting on a quick deal
SpaceX IPO Turns Thousands of Workers Into Millionaires - For Now
SpaceX’s record-breaking IPO minted over 4,400 employee millionaires, from welders to executives, but falling share prices and strict lockup rules mean most can’t cash out yet and face real risks to their newfound wealth
Top Analyst Warns AMD Stock May Be Priced for Perfection
AMD’s rapid stock gains have outpaced the broader market, but a leading Wall Street analyst cautions that much of the company’s AI-driven upside may already be reflected in its valuation
Goldman Sachs Lifts Applied Materials Target as Chip Spending Surges
Applied Materials stock has soared 127% in 2026, prompting Goldman Sachs to raise its price target to $645. The move reflects confidence in long-term chip equipment demand, but investors face new risks as the rally outpaces the broader market
Mag 7 Stocks Drop $2.3 Trillion as Investors Miss Key AI Shift
The Magnificent Seven lost over $2 trillion in value since mid-May, but Jim Cramer argues investors are misreading the AI spending cycle and could miss the next rally if they treat these tech giants as a single trade
How SpaceX’s Nasdaq-100 Debut Impacts Your 401(k) Investments
SpaceX’s rapid entry into the Nasdaq-100 means millions of Americans now hold a stake in Elon Musk’s company through index funds, even if they never bought the stock directly. Here’s what that means for your retirement portfolio and risk exposure
Nvidia Stock Faces $1 Trillion Drop as Citi Sees Opportunity
Nvidia shares have fallen 16% since their May peak, erasing about $1 trillion in market value. Citi analysts maintain a bullish outlook, citing a strong product roadmap and buyback plans despite investor concerns
Bank of America Doubles Down on Meta Despite AI Spending Fears
Meta’s stock has lagged in 2026 as Wall Street debates the payoff of its massive AI infrastructure investments. Bank of America’s latest move signals renewed conviction, but investors face key milestones and risks in the months ahead
Market Rotation Sends These 5 Stocks Lower - Are They Now a Bargain
A weak June jobs report triggered a sharp rotation out of defensive stocks, pushing down shares of Johnson & Johnson, PepsiCo, Starbucks, Constellation Brands, and TJX. Here’s why some investors see opportunity—and what could go wrong next
Rocket Lab’s $8 Billion Iridium Deal Raises Stakes in Space Race
Morgan Stanley sharply increased its bull case for Rocket Lab after the company’s $8 billion Iridium acquisition, signaling a new phase in the competition to capture recurring revenue from satellite connectivity and launch services